Culture of human epidermal Langerhans cells in a skin equivalent

British Journal of Dermatology

Volumn 139, Issue 4, 1998, Pages 598-604

  Fransson, J ^a   Heffler, L C ^a   Linder, M Tengvall ^a   Scheynius, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CELL DENSITY; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN CULTURE;

CELLS, CULTURED; CULTURE MEDIA; CYCLOSPORINE; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; SKIN, ARTIFICIAL; STAINING AND LABELING;

EID: 0031692117     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02454.x     Document Type: Article

References (37)

1. Kripke ML, Munn CG, Jeevan A et al. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145: 2833-8.
2. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-96.
3. Richters CD, Hoekstra MJ, van Baare J et al. Isolation and characterization of migratory human skin dendritic cells. Clin Exp Immunol 1994; 98: 330-6.
4. Régnier M, Staquet M-J, Schmitt D, Schmidt R. Integration of Langerhans cells into a pigmented reconstructed human epidermis. J Invest Dermatol 1997; 109: 510-2.
5. Compton CC, Gill JM, Bradford DA et al. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. A light, electron microscopic and immunohistochemical study. Lab Invest 1989; 60: 600-12.
6. Reid CDL, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 1992; 149: 2681-8.
7. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 1992; 52: 274-81.
8. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic langerhans cells. Nature 1992; 360: 258-61.
9. Xu S, Ariizumi K, Edelbaum D et al. Cytokine-dependent regulation of growth and maturation in murine epidermal dendritic cell lines. Eur J Immunol 1995; 25: 1018-24.
10. Furue M, Katz, SI. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro. J Immmunol 1988; 140: 4139-43.
11. Péguet-Navarro J, Slaats M, Thivolet J. Lack of demonstrable effect of cyclosporin A on human epidermal Langerhans cell function. Arch Dermatol Res 1991; 283: 198-202.
12. Belsito DV, Epstein SP, Schultz JM et al. Enhancement by various cytokines or 2-β-mercaptoethanol of 1a antigen expression on Langerhans cells in skin from normal aged and young mice. Effect of cyclosporine. J Immunol 1989; 143: 1530-6.
13. Coulomb B, Saiag P, Bell E, et al. A new method for studying epidermalization in vitro. Br J Dermatol 1986; 114: 91-101.
14. Fransson J, Emilson A, Scheynius A, Hammar H. Proliferation and interferon-γ receptor expression in psoriatic and healthy keratinocytes are influenced by interactions between keratinocytes and fibroblasts in a skin equivalent model. Arch Dermatol Res 1995; 287: 517-23.
15. Fransson J, Hammar H. Epidermal growth in the skin equivalent. Arch Dermatol Res 1992; 284: 343-8.
16. Bell E, Ehrlich H, Sher S et al. Development and use of a living skin equivalent. Plast Reconstr Surg 1981; 67: 386-92.
17. Mansbridge JN, Knapp AM. Changes in keratinocyte maturation during wound healing. J Invest Dermatol 1987; 89: 253-63.
18. Oliver AM, Kaawach W, Weiler Mithoff E et al. The differentiation and proliferation of newly formed epidermis on wounds treated with cultured epithelial allografts. Br J Dermatol 1991; 125: 147-54.
19. Kashihara M, Ueda M, Horiguchi Y et al. A monoclonal antibody specifically reactive to human Langerhans cells. J Invest Dermatol 1986; 87: 602-7.
20. Fithian E, Kung P, Goldstein G et al. Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci USA 1988; 78: 2541-4.
21. Zhou L-J, Schwarting R, Smith HM, Tedder TF. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 1992; 149: 735-42.
22. Zhou L-J, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996; 95: 2588-92.
23. Girolomoni G, Zambruno G, Manfredini R et al. Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. J Invest Dermatol 1994; 103: 54-9.
24. Inaba K, Witmer-Pack M, Inaba M et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994; 180: 1849-60.
25. Rattis F-M, Péguet-Navarro J, Staquet M-J et al. Expression and function of B7-1 (CD80) and B7-2 (CD86): on human epidermal Langerhans cells. Eur J Immunol 1996; 26: 449-53.
26. Larsen CP, Ritchie SC, Hendrix R et al. Regulation of immunostimulatory function and costimulalory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152: 5208-19.
27. Proksch E, Brasch J, Sterry W. Integrity of the permeability barrier regulates epidermal Langerhans cell density. Br J Dermatol 1996; 134: 650-8.
28. Fransson J, Shen Q, Scheynius A, Hammar H. The effect of TFN-γ on healthy and psoriatic keratinocytes in a skin equivalent model is influenced by the source of the keratinocytes and by their interactions with fibroblasts. Arch Dermatol Res 1996; 289: 14-20.
29. Cerio R, Griffiths CEM, Cooper KD et al. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989; 121: 421-31.
30. Kobayashi Y, Staquet M-J, Dezutter-Dambuyant C, Schmitt D. Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact. Eur J Immunol 1994; 24: 2254-7.
31. Aldridge RD, Thomson AW, Rankin R et al. Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig. Clin Exp Immunol 1985; 59: 23-8.
32. Halliday GM, Knight BA, Muller HK. Reduction in murine Langerhans cell in ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants. Br J Dermatol 1986; 114: 83-9.
33. Urabe A, Haftek M, Kanitakis J et al. Cyclosporin A does not modify Langerhans cell number and distribution in normal human skin. Acta Derm Venereol (Stockh) 1989; 69: 249-52.
34. Rambukkana A, Bos JD, Irik D et al. In situ behavior of human Langerhans cells in skin organ culture. Lab Invest 1995; 73: 521-31.
35. Rambukkana A, Pistoor FHM, Bos JD et al. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1β protein. Lab Invest 1996; 74: 422-36.
36. Pistoor FHM, Rambukkana A, Kroezen M et al. Novel predictive assay for contact allergens using human skin explant cultures. Am J Pathol 1996; 149: 337-43.
37. Scheynius A, Fransson J, Johansson C et al. Expression of interferon-gamma receptors in normal and psoriatic skin. J Invest Dermatol 1992; 98: 255-8.